400
Participants
Start Date
June 14, 2020
Primary Completion Date
December 15, 2020
Study Completion Date
December 15, 2020
Convalescent Plasma
Dose-250 ml Frequency - 2 doses on consecutive days Duration -Start by day 3 of symptom onset (of severe COVID-19 as in inclusion criteria) in eligible patients
Standard of Care
The Ministry of Health and Family Welfare has issued detailed guidelines for the management of sCOVID-19 based on varying grades of severity which may be periodically updated. For the management of ARDS or sepsis the respective guidelines issued by ARDSNet and Surviving Sepsis campaign will be followed. Other institutional protocols for supportive management will be implemented. (Ref: Guidelines on Clinical Management of COVID-19. MoHFW, GoI.2020.)
Maulana Azad Medical College, New Delhi
Institute of Liver & Biliary Sciences, New Delhi
Rajiv Gandhi Super Speciality Hospital, New Delhi
Institute of Liver and Biliary Sciences, India
OTHER